By ...

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara authored the chapter "Personalised medicine in Brazil: IP and regulatory challenges". This article first … Personalised medicine in Brazil: IP and regulatory challenges

In a tight vote, the Special Committee of the Chamber of Deputies approved this Tuesday, June 8, Bill No. 399/2015 (PL 399/2015), … Special Committee of the Chamber of Deputies approves Bill No. 399/2015, on medical, veterinary and industrial uses of Cannabis

ANVISA’s Board of Directors opened a Public Consultation (“PC 1,039/2021”), available to contributions between 04/15/2021 and 06/15/2021, to discuss a proposed regulation … ANVISA opens a Public Consultation to improve the reliance on foreign regulatory authorities’ opinions

Changes in the preliminary injunction granted by the Brazilian Supreme Court   As per our Newsletter No. 7/2021, on April 7th, 2021, … The Term of Patents in Brazil: what a difference a day makes!

The Global Practice Guide, published by Chambers & Partners, includes outlines of national regimes, fundamental laws, sectoral or special issues, workplace privacy, … Data Protection & Privacy in Brazil 2021: Global Practice Guide by Chambers & Partners

On December 2, 2020, through its Commission on Narcotics, the United Nations approved a recommendation issued by WHO – World Health Organization … UN removes Cannabis from List of Narcotic Substances

On November 17th, 2020, ANVISA’s Board of Directors (BoD) unanimously granted an administrative appeal for reassessment of prior consent of a patent … ANVISA decides that a patent application related to pharmaceutical use of cannabinoids is not to be deemed as against public health

On November 5, Anvisa published Resolution – RDC 432/2020 which sets forth an obligation to describe the list of ingredients in Portuguese … ANVISA establishes new rules for labeling of personal care products, cosmetics and perfumes

Our partner and Head of Regulatory Anderson Ribeiro, together with his associates Lucas Calabria and Matheus Montecasciano, co-sign the chapter “Pharma & … Pharma & Medical Device Regulation in Brazil

After a 6 years debate, Anvisa’s Board approved a new regulatory framework for food labeling during its meeting held on October 8th, … Anvisa approves new regulations for food labeling

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil … Biologics and biosimilars in Brazil – the strategic questions

The Global Practice Guide, published by Chambers & Partners, includes outlines of national regimes, fundamental laws, sectoral or special issues, workplace privacy, … Data Protection & Privacy in Brazil 2020: Global Practice Guide by Chambers & Partners

A Q&A guide to pharmaceutical IP and competition law in Brazil. The Q&A gives a high level overview of key issues including … Pharmaceutical IP and competition law in Brazil: 2019

ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate: (i) the cultivation of the cannabis spp. for … Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes

The Global Practice Guide, published by Chambers & Partners, provide easily accessible information on navigating the legal system when conducting business in … Data Protection & Cybersecurity in Brazil 2019: Global Practice Guide by Chambers & Partners